Sort by
Refine Your Search
-
following treatment. NEWDAY-ABC is a hybrid intervention-implementation trial that will be carried out at four sites across Yorkshire and Greater Manchester. The parallel process evaluation will assess
-
, Physical and Life Sciences Division at Oxford may be found at www.medsci.ox.ac.uk/departments and www.mpls.ox.ac.uk/departments https://www.humanities.ox.ac.uk/faculties-and-units-0 and https
-
Medicine Clinical Research Facility (EMCRF) (https://www.kennedy.ox.ac.uk/news/oxford-and-gsk-launch-experimental-medicine-collaboration ). This will allow testing of multiple medicines across cellular
-
capabilities, and particularly the Experimental Medicine Clinical Research Facility (EMCRF) (https://www.kennedy.ox.ac.uk/news/oxford-and-gsk-launch-experimental-medicine-collaboration). This will allow testing
-
distortions in the presence of a shallow crustal hydrothermal system at a model caldera volcano. The model will use the phase field approach and be implemented in Alya, the parallel multi-physics Computation
-
Please apply here: https://apply.workable.com/ellison-institute-of-technology/j/91F1A5719B/apply/ Led by a world-class faculty of scientists, technologists, policy makers, economists and